The invention discloses a
traditional Chinese medicine composition for treating
hepatitis and
liver cancer, comprising the following
raw material medicines according to parts by weight: 1 to 120 parts of rhein or rhubarb class substances capable of being metabolized into the rhein
in vivo, 1 to 50 parts of
quercetin or quercetinic acid
glucoside class substances capable of metabolized into the quercetinic acid
in vivo and 3 to 60 parts of vinegar
radix bupleuri, wherein the rhein is a market-sold product artificially synthesized or naturally extracted, and the purity is more than or equal to 80%. The composition can be prepared into various
traditional Chinese medicine preparation medicines which can suppress the multiplication of
liver cancer cells and promote the death of the
liver cancer cells; an animal experiment validates that compared with the original anticancer
medicine, the
medicine can greatly enhance the concentration of the
medicine in the liver and prolong the detention time of the medicine.